Structure-based docking, pharmacokinetic evaluation, and molecular dynamics-guided evaluation of traditional formulation against SARS-CoV-2 spike protein receptor bind domain and ACE2 receptor complexOriginal Paper Published on 2021-10-182022-10-31 Journal: Chemicke Zvesti [Category] COVID-19, [키워드] ACE2 ACE2 receptor Analysis angiotensin-converting enzyme 2 antiviral property binding caffeic acid Cell classical clinical trial complex Computational docking study docking docking score domain Favipiravir FIVE Glide in silico in vivo experiment Interaction Kabasura kudineer Ligand MD simulation molecular molecular dynamics nontoxic outbreak pandemic PDB pharmacokinetic preventive measure Protein RBD receptor residue ribavirin SARS-CoV-2 SARS-CoV-2 spike protein selected Selection Shwas kuthar rasa Siddha suggested supplementary material Talisadi churna the SARS-CoV-2 therapeutic viral entry was performed was used [DOI] 10.1007/s11696-021-01917-z PMC 바로가기 [Article Type] Original Paper